Showing results (51-60 of 648) with videos related to

Sort By:
Pageof 65
International Journal of Cancer|August 15, 1987
Phenotype versus immunoglobulin and T-cell receptor genotype of Hodgkin-derived cell lines: activation of immature lymphoid cells in Hodgkin's diseaseM H Falk, H Tesch, H Stein, et al.
Blood|October 9, 1998
Detection of clonal Hodgkin and Reed-Sternberg cells with identical somatically mutated and rearranged VH genes in different biopsies in relapsed Hodgkin's diseaseM Vockerodt, M Soares, H Kanzler, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|July 1, 1997
[31P-MR spectroscopy of the human liver--the spectral indications of lymphoma infiltration]W Heindel, R du Mesnil de Rochemont, H Kugel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Favorable outcome of patients with relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dex-BEAM)A Josting, I Kàtay, U Rueffer, et al.
Blood|September 15, 1993
Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodiesH Bohlen, T Hopff, O Manzke, et al.
Cancer Research|September 15, 1993
Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodiesH Bohlen, O Manzke, B Patel, et al.
The Journal of Infection|March 25, 1999
Two cases of toxoplasmic encephalitis in patients with acute T-cell leukaemia and lymphomaD Re, M Reiser, S Bamborschke, et al.
Cytokines and Molecular Therapy|December 1, 1996
Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growthH Bohlen, K Thielemanns, H Tesch, et al.
British Journal of Haematology|May 3, 2000
Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspectsS Titzer, O Christensen, O Manzke, et al.
Leukemia & Lymphoma|April 30, 1999
Dexa-BEAM is not effective in patients with relapsed or resistant aggressive high-grade non-Hodgkin's lymphomaM Reiser, A Josting, P Dias Wickramanayake, et al.
Pageof 65